Supplementary Figure S7 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
Fields of Study & Subjects
Breast Cancer Treatment Studies
Estrogen and related hormone effects
Genomics
phytochemicals
and oxidative stress
Publication details
- Publication date
- 27 February 2026
- Language
- EN